Antiarrhythmic Drug Dosing in Children-Review of the Literature
Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone, and esmolol), while there are only very broad dosage recommendations for others (such as sotalol or digoxin). To prevent potential uncertainties and even mistakes with regard to dosing, we summarized the published dosage recommendations for antiarrhythmic drugs in children. Because of the wide variations in availability, regulatory approval, and experience, we encourage centers to develop their own specific protocols for pediatric antiarrhythmic drug therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Children (Basel, Switzerland) - 10(2023), 5 vom: 08. Mai |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oeffl, Nathalie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antiarrhythmic drugs |
|---|
| Anmerkungen: |
Date Revised 30.05.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/children10050847 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357406222 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357406222 | ||
| 003 | DE-627 | ||
| 005 | 20231226072526.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/children10050847 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1191.xml |
| 035 | |a (DE-627)NLM357406222 | ||
| 035 | |a (NLM)37238395 | ||
| 035 | |a (PII)847 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oeffl, Nathalie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antiarrhythmic Drug Dosing in Children-Review of the Literature |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.05.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone, and esmolol), while there are only very broad dosage recommendations for others (such as sotalol or digoxin). To prevent potential uncertainties and even mistakes with regard to dosing, we summarized the published dosage recommendations for antiarrhythmic drugs in children. Because of the wide variations in availability, regulatory approval, and experience, we encourage centers to develop their own specific protocols for pediatric antiarrhythmic drug therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a antiarrhythmic drugs | |
| 650 | 4 | |a arrhythmia | |
| 650 | 4 | |a children | |
| 650 | 4 | |a drug dosing | |
| 650 | 4 | |a electrophysiology | |
| 700 | 1 | |a Schober, Lukas |e verfasserin |4 aut | |
| 700 | 1 | |a Faudon, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Schweintzger, Sabrina |e verfasserin |4 aut | |
| 700 | 1 | |a Manninger, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Köstenberger, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Sallmon, Hannes |e verfasserin |4 aut | |
| 700 | 1 | |a Scherr, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Kurath-Koller, Stefan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Children (Basel, Switzerland) |d 2014 |g 10(2023), 5 vom: 08. Mai |w (DE-627)NLM246337737 |x 2227-9067 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:5 |g day:08 |g month:05 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/children10050847 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2023 |e 5 |b 08 |c 05 | ||